Variant report

Variant	nsv576636
Chromosome Location	chr18:29146822-29190174
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr18:29147012-29147181	HepG2	liver:	n/a	n/a
2	ARID3A	chr18:29171157-29172132	HepG2	liver:	n/a	n/a
3	ARID3A	chr18:29176005-29176447	HepG2	liver:	n/a	n/a
4	ARID3A	chr18:29166577-29167110	HepG2	liver:	n/a	chr18:29166636-29166652
5	ARID3A	chr18:29175473-29175517	HepG2	liver:	n/a	n/a
6	ARID3A	chr18:29167488-29167920	HepG2	liver:	n/a	n/a
7	ARID3A	chr18:29187408-29187649	HepG2	liver:	n/a	n/a
8	ARID3A	chr18:29186073-29186697	HepG2	liver:	n/a	n/a
9	BHLHE40	chr18:29187380-29187713	HepG2	liver:	n/a	n/a
10	CEBPB	chr18:29163156-29163514	HepG2	liver:	n/a	chr18:29163337-29163348 chr18:29163335-29163346 chr18:29163335-29163348
11	CEBPB	chr18:29146982-29147102	HepG2	liver:	n/a	n/a
12	CEBPB	chr18:29167526-29167879	HepG2	liver:	n/a	n/a
13	CEBPB	chr18:29154433-29154633	K562	blood:	n/a	n/a
14	CEBPB	chr18:29186336-29186574	HepG2	liver:	n/a	n/a
15	CEBPB	chr18:29163219-29163456	HepG2	liver:	n/a	chr18:29163337-29163348 chr18:29163335-29163346 chr18:29163335-29163348
16	CEBPB	chr18:29186848-29187105	HepG2	liver:	n/a	chr18:29186986-29186997 chr18:29186984-29186995
17	CEBPB	chr18:29161493-29161718	HepG2	liver:	n/a	n/a
18	CEBPB	chr18:29153100-29153223	HepG2	liver:	n/a	chr18:29153159-29153170 chr18:29153158-29153171
19	CEBPB	chr18:29153000-29153358	HepG2	liver:	n/a	chr18:29153159-29153170 chr18:29153158-29153171
20	CEBPB	chr18:29157568-29157795	HepG2	liver:	n/a	n/a
21	CEBPB	chr18:29187521-29187620	HepG2	liver:	n/a	n/a
22	CEBPB	chr18:29186983-29187031	K562	blood:	n/a	chr18:29186986-29186997 chr18:29186984-29186995
23	CEBPB	chr18:29153010-29153359	HepG2	liver:	n/a	chr18:29153159-29153170 chr18:29153158-29153171
24	CEBPD	chr18:29171699-29171999	HepG2	liver:	n/a	n/a
25	CEBPD	chr18:29171661-29171985	HepG2	liver:	n/a	n/a
26	CHD2	chr18:29157750-29157892	K562	blood:	n/a	n/a
27	CTCF	chr18:29161681-29161703	GM20000	blood:	n/a	n/a
28	CTCF	chr18:29153483-29153503	GM10248	blood:	n/a	n/a
29	CTCF	chr18:29146860-29147010	HRPEpiC	eye:	n/a	chr18:29146972-29146993 chr18:29146977-29146995 chr18:29146979-29146992
30	CTCF	chr18:29153810-29153886	GM13976	blood:	n/a	n/a
31	CTCF	chr18:29150521-29150607	LNCaP	prostate:	n/a	n/a
32	CTCF	chr18:29180320-29180470	HRPEpiC	eye:	n/a	n/a
33	CTCF	chr18:29160880-29161030	GM12867	blood:	n/a	n/a
34	CTCF	chr18:29177707-29177797	LNCaP	prostate:	n/a	n/a
35	E2F4	chr18:29179899-29179999	MCF10A-Er-Src	breast:	n/a	n/a
36	EBF1	chr18:29157178-29157504	GM12878	blood:	n/a	chr18:29157383-29157394 chr18:29157481-29157490
37	EBF1	chr18:29157231-29157556	GM12878	blood:	n/a	chr18:29157383-29157394 chr18:29157481-29157490
38	EBF1	chr18:29157151-29157506	GM12878	blood:	n/a	chr18:29157383-29157394 chr18:29157481-29157490
39	ELF1	chr18:29163293-29163498	HepG2	liver:	n/a	n/a
40	ELK1	chr18:29165906-29165916	K562	blood:	n/a	n/a
41	EP300	chr18:29161672-29162235	SK-N-SH	brain:	n/a	n/a
42	EP300	chr18:29167432-29167960	HepG2	liver:	n/a	n/a
43	EP300	chr18:29171462-29172038	HepG2	liver:	n/a	n/a
44	EP300	chr18:29167465-29167861	HepG2	liver:	n/a	n/a
45	EP300	chr18:29186159-29186619	HepG2	liver:	n/a	n/a
46	EP300	chr18:29186218-29186590	HepG2	liver:	n/a	n/a
47	EP300	chr18:29163179-29163688	HepG2	liver:	n/a	n/a
48	EP300	chr18:29175903-29176372	SK-N-SH_RA	brain:	n/a	n/a
49	EP300	chr18:29171534-29171932	HepG2	liver:	n/a	n/a
50	EP300	chr18:29176078-29176431	HepG2	liver:	n/a	chr18:29176414-29176423

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr18:29170928-29170978	AG04450	lung:	fetal
2	chr18:29171878-29171928	GM19239	blood:	n/a
3	chr18:29171977-29172027	SKMC	muscle:	n/a
4	chr18:29171977-29172027	HCPEpiC	choroid plexus:	n/a
5	chr18:29171545-29171595	Caco-2	colon:	n/a
6	chr18:29170928-29170978	HRPEpiC	eye:	n/a
7	chr18:29178942-29178992	AG04449	skin:	fetal
8	chr18:29171977-29172027	BE2_C	brain:	n/a
9	chr18:29178942-29178992	HCPEpiC	choroid plexus:	n/a
10	chr18:29178942-29178992	K562	blood:	n/a
11	chr18:29171545-29171595	AG04449	skin:	fetal
12	chr18:29170928-29170978	NB4	blood:	n/a
13	chr18:29171977-29172027	SK-N-SH_RA	brain:	n/a
14	chr18:29178454-29178504	U87	brain:	n/a
15	chr18:29171878-29171928	SK-N-MC	brain:	n/a
16	chr18:29171545-29171595	PANC-1	pancreas:	n/a
17	chr18:29171878-29171928	HUVEC	blood vessel:	n/a
18	chr18:29171545-29171595	LNCaP	prostate:	n/a
19	chr18:29170604-29170654	NT2-D1	testis:	n/a
20	chr18:29171545-29171595	GM12892	blood:	n/a
21	chr18:29178942-29178992	CMK	blood:	n/a
22	chr18:29171977-29172027	BJ	skin:	n/a
23	chr18:29171545-29171595	AG09319	gingival:	n/a
24	chr18:29171545-29171595	HNPCEpiC	eye:	n/a
25	chr18:29171545-29171595	GM06990	blood:	n/a
26	chr18:29178454-29178504	A549	lung:	n/a
27	chr18:29171878-29171928	Hela-S3	cervix:	n/a
28	chr18:29171545-29171595	PrEC	prostate:	n/a
29	chr18:29178454-29178504	SK-N-SH_RA	brain:	n/a
30	chr18:29171977-29172027	HPAEpiC	pulmonary alveolar:	n/a
31	chr18:29170928-29170978	HPAEpiC	pulmonary alveolar:	n/a
32	chr18:29171977-29172027	HEK293	kidney:	embryo
33	chr18:29171545-29171595	ECC-1	luminal epithelium:	n/a
34	chr18:29170604-29170654	PrEC	prostate:	n/a
35	chr18:29170928-29170978	HRCEpiC	kidney:	n/a
36	chr18:29171878-29171928	HCM	heart:	n/a
37	chr18:29171977-29172027	ovcar-3	ovarian:	n/a
38	chr18:29171545-29171595	BE2_C	brain:	n/a
39	chr18:29178942-29178992	GM12878	blood:	n/a
40	chr18:29171545-29171595	HCF	heart:	n/a
41	chr18:29171545-29171595	SK-N-SH_RA	brain:	n/a
42	chr18:29170928-29170978	PrEC	prostate:	n/a
43	chr18:29170928-29170978	GM19239	blood:	n/a
44	chr18:29171878-29171928	AG04449	skin:	fetal
45	chr18:29171878-29171928	GM06990	blood:	n/a
46	chr18:29170928-29170978	U87	brain:	n/a
47	chr18:29170604-29170654	BJ	skin:	n/a
48	chr18:29170604-29170654	HIPEpiC	eye:	n/a
49	chr18:29171878-29171928	H1-hESC	embryonic stem cell:	embryo
50	chr18:29171977-29172027	NT2-D1	testis:	n/a

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr18:29077257..29078903-chr18:29144506..29147477,2	MCF-7	breast:

Variant related genes	Relation type
TTR	TF binding region
TTR	CpG island
ENSG00000046604	chromatin interactions

Extended variants
information (count: 1765 )
Associated
traits (count: 71 )

Variant overlapped rSNPs/rCNVs (count:1765 , 50 per page) page: 1 2 3 4 5 6 7 ... 36

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs9304102	chr18:29146822-29146823	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs1791218	chr18:29146918-29146919	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
3	rs9963959	chr18:29146950-29146951	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs149205391	chr18:29146957-29146958	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
5	rs556026491	chr18:29146958-29146959	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs9963820	chr18:29146968-29146969	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
7	rs9963742	chr18:29146984-29146985	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs185024425	chr18:29146986-29146987	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
9	rs115045971	chr18:29147029-29147030	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs75652801	chr18:29147039-29147040	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs563796038	chr18:29147088-29147089	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs530934977	chr18:29147139-29147140	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs143038106	chr18:29147145-29147146	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs560760784	chr18:29147162-29147163	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs528338811	chr18:29147193-29147194	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs546492476	chr18:29147196-29147197	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs4315413	chr18:29147226-29147227	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs148183935	chr18:29147254-29147255	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs550350989	chr18:29147273-29147274	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
20	rs191536037	chr18:29147333-29147334	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs73418151	chr18:29147336-29147337	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs116693803	chr18:29147347-29147348	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs371994260	chr18:29147360-29147361	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
24	rs567883781	chr18:29147363-29147364	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
25	rs564239616	chr18:29147477-29147478	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
26	rs187149423	chr18:29147478-29147479	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs553713612	chr18:29147480-29147481	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs578218631	chr18:29147484-29147485	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs576415422	chr18:29147496-29147497	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs545362994	chr18:29147613-29147614	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs557108707	chr18:29147638-29147639	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs1629309	chr18:29147649-29147650	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs542731695	chr18:29147673-29147674	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs140074014	chr18:29147705-29147706	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs528279506	chr18:29147714-29147715	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs540076639	chr18:29147717-29147718	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs545462044	chr18:29147718-29147719	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs114919013	chr18:29147767-29147768	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs532332821	chr18:29147817-29147818	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs550536082	chr18:29147824-29147825	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs150330983	chr18:29147909-29147910	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs201276303	chr18:29147936-29147937	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs199582056	chr18:29147937-29147938	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs200579429	chr18:29147938-29147939	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs529786916	chr18:29148022-29148023	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs1620754	chr18:29148072-29148073	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs78838551	chr18:29148074-29148075	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs535223358	chr18:29148075-29148076	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs137934430	chr18:29148118-29148119	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs571892571	chr18:29148134-29148135	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:71)

Disease	PMID	Source
Esophageal squamous carcinoma	18350619	CNVD
Follicular lymphoma	20505157	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Neuroblastoma	18923191	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Medulloblastoma	21979893	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Trisomy 18 syndrome	17576883	CNVD
lymphocytic leukemia	21291569	CNVD
Barrett''s syndrome	19417022	CNVD
Ewing''s sarcoma	17952124	CNVD
Multiple myeloma	17550852	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Glioblastoma multiforme	21922591	CNVD
Melanoma	18172304	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Lung cancer	18438408	CNVD
18q deletion syndrome	19533772	CNVD
Acute myeloid leukemia	16864856	CNVD
Colorectal cancer	21102417	CNVD
Colorectal cancer	20709793	CNVD
Pancreatic cancer	21811562	CNVD
Basal cell lymphoma	21115979	CNVD
Mucosa-associated lymphoid tissue lymphomas	21459788	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
colon cancer	17210682	CNVD
Breast cancer	21785460	CNVD
Hepatocellular carcinoma	16750200	CNVD
Prostate cancer	16573809	CNVD
Autism	16446308	CNVD
Colorectal cancer	19359472	CNVD
Colorectal cancer	16272173	CNVD
Human rectal carcinomas	16397240	CNVD
Medulloblastoma	18056178	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Cancer	16751803	CNVD
Metanephric adenoma	20802469	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	17133270	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Colorectal cancer	16774939	CNVD
Colorectal cancer	21297112	CNVD
Myelofibrosis	22110671	CNVD
Colorectal cancer	21645411	CNVD
Glioblastoma multiforme	17002787	CNVD
Cancer	21183584	CNVD
Breast cancer	17603634	CNVD
Thyroid cancer	19087340	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
Colorectal cancer	16912164	CNVD
Renal cell carcinoma	19150565	CNVD
Multiple myeloma	16616336	CNVD
Colorectal cancer	19150955	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	21364760	CNVD
Pancreatic cancer	21811587	CNVD
Breast cancer	22522925	CNVD
Prostate cancer	22341455	CNVD

Chromatin state (count:300 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr18:29144200-29147600	Enhancers	Fetal Intestine Large	intestine
2	chr18:29145400-29147600	Enhancers	Fetal Intestine Small	intestine
3	chr18:29146000-29147200	Enhancers	Rectal Mucosa Donor 31	rectum
4	chr18:29146200-29147000	Enhancers	Duodenum Mucosa	Duodenum
5	chr18:29146200-29147000	Flanking Active TSS	HepG2	liver
6	chr18:29146600-29147000	Enhancers	Sigmoid Colon	Sigmoid Colon
7	chr18:29146600-29147400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
8	chr18:29146600-29156600	Weak transcription	Pancreatic Islets	Pancreatic Islet
9	chr18:29146800-29147000	Enhancers	Colonic Mucosa	Colon
10	chr18:29146800-29147000	Bivalent Enhancer	Stomach Mucosa	stomach
11	chr18:29146800-29147200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
12	chr18:29146800-29147800	Enhancers	Liver	Liver
13	chr18:29147000-29148000	Enhancers	HepG2	liver
14	chr18:29147400-29148000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
15	chr18:29147600-29150000	Weak transcription	Fetal Intestine Large	intestine
16	chr18:29147600-29151800	Weak transcription	Fetal Intestine Small	intestine
17	chr18:29147800-29151400	Weak transcription	Liver	Liver
18	chr18:29148000-29152000	Weak transcription	HepG2	liver
19	chr18:29150000-29150400	Enhancers	Fetal Intestine Large	intestine
20	chr18:29150400-29151600	Weak transcription	Fetal Intestine Large	intestine
21	chr18:29151200-29152200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
22	chr18:29151400-29152400	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
23	chr18:29151400-29152600	Enhancers	Liver	Liver
24	chr18:29151400-29152800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
25	chr18:29151400-29154200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
26	chr18:29151600-29152000	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
27	chr18:29151600-29152000	Enhancers	iPS-20b Cell Line	embryonic stem cell
28	chr18:29151600-29152200	Enhancers	HUES6 Cell Line	embryonic stem cell
29	chr18:29151600-29152400	Enhancers	Primary hematopoietic stem cells	blood
30	chr18:29151600-29157600	Enhancers	Fetal Intestine Large	intestine
31	chr18:29151800-29152200	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
32	chr18:29151800-29154000	Enhancers	Fetal Intestine Small	intestine
33	chr18:29152000-29152200	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
34	chr18:29152000-29156000	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
35	chr18:29152000-29157400	Enhancers	HepG2	liver
36	chr18:29152200-29152400	Flanking Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
37	chr18:29152200-29154400	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
38	chr18:29152400-29152600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
39	chr18:29152400-29152600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
40	chr18:29152400-29156200	Weak transcription	Primary hematopoietic stem cells	blood
41	chr18:29152600-29153000	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
42	chr18:29152600-29153400	Flanking Active TSS	Liver	Liver
43	chr18:29152800-29153000	Enhancers	Primary hematopoietic stem cells short term culture	blood
44	chr18:29152800-29153400	Enhancers	Adipose Nuclei	Adipose
45	chr18:29152800-29153600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
46	chr18:29152800-29156000	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
47	chr18:29153400-29155400	Enhancers	Liver	Liver
48	chr18:29153600-29161400	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
49	chr18:29153800-29156000	Weak transcription	Primary hematopoietic stem cells short term culture	blood
50	chr18:29154000-29154400	Weak transcription	Fetal Intestine Small	intestine

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links